论文部分内容阅读
对６３例（只眼）丝状真菌性角膜炎分别应用Ⅰ组１％克霉唑混悬液（１６例）、Ⅱ组１％咪康唑混悬液（２３例）及Ⅲ组复方咪康唑合剂（１５例）滴眼、Ⅳ组复方咪康唑合剂滴眼联合酮康唑口服进行治疗。各组治愈率分别为２５％、２１％、６６．６％、７７．７％，第Ⅰ、Ⅱ组与第Ⅲ、Ⅳ组比较差异有显著性（Ｐ＜０．０１），Ⅲ、Ⅳ组之间比较差异虽无显著性（Ｐ＞０．１），但平均治愈无数；组为６８天，Ⅳ组为３５天，差异有显著性（Ｐ＜０．０１），认为复方咪康唑合剂滴眼联合酮康唑口服是当前国内治疗丝状真菌性角膜炎的一种较好方法，值得推广应用。
Sixty-three cases (group I) of clotrimazole suspension (group Ⅰ), 1% miconazole group Ⅱ (group Ⅱ) and group Ⅲ Azole mixture (15 cases) eye drops, Ⅳ group of compound miconazole mixture eye drops combined with ketoconazole oral treatment. The cure rates in each group were 25%, 21%, 66.6% and 77.7%, respectively. There were significant differences between groups Ⅰ and Ⅱ and groups Ⅲ and Ⅳ (P <0.01) (P> 0.1), but the average cure was numerous; group 68 days, group IV 35 days, the difference was significant (P <0.01), that the combination of miconazole mixture Eye drops combined with ketoconazole oral treatment of filamentous fungal keratitis is currently a good way, it is worth promoting the application.